Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Santa Marta Golden Hemp, as Avicanna's majority-owned Colombian subsidiary, is fully licensed and vertically integrated for cannabis cultivation, extraction, and manufacturing. It supplies feminized seeds, purified cannabinoid extracts (CBD, CBG, THC), and active pharmaceutical ingredients (APIs) for cosmetic, medical, and pharmaceutical end-use. The company has successfully exported its products (including standardized genetics and GMP-grade cannabinoid APIs) to over 19 international markets, including recent entries into Spain, Portugal, and Denmark, and meets G.A.P and G.M.P. requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Santa Marta Golden Hemp.